US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Chicago Rivet & Machine

12.39

+0.47333.97%

Post-market: 12.390.00000.00%16:05 EDT

Volume:9.70K

Turnover:121.82K

Market Cap:11.97M

PE:-2.13

High:13.80

Open:11.82

Low:11.28

Close:11.92

Loading ...

Overview Company News Filings

Press Release: Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million

CVR Energy (CVI) Receives a Sell from Scotiabank

CVR Energy Prices $325 Million Term Loan; Negotiating for Sale of Assets

MT Newswires Live

CVR Energy Announces New Executive Employment Agreement

CVR Energy’s Strategic Moves: Tender Offer and Financing

Press Release: CVR Energy Announces Pricing of Proposed Senior Secured Term Loan B Facility, 2025 Capital Expenditure Outlook, New Employment Agreement with Dave Lamp

NLS Pharmaceutics CEO Issues Letter to Shareholders

Icahn Enterprises launches public bid to boost stake in CVR Energy

Icahn Enterprises' Latest Tender Offer Looks to Boost Its Stake in CVR Energy

Press Release: ICAHN ENTERPRISES L.P. AND ICAHN ENTERPRISES HOLDINGS L.P. ANNOUNCE COMMENCEMENT OF TENDER OFFER FOR UP TO 17,753,322 SHARES OF COMMON STOCK OF CVR ENERGY

Coloplast A/S - Decisions at the Annual General Meeting 2024

The Zacks Analyst Blog Highlights Roche, Poseida Therapeutics, Merck, AstraZeneca and Novartis

Pharma Stock Roundup: RHHBY to Buy PSTX, MRK, AZN See Pipeline Success

Carl Icahn Increases Stake in CVR Partners LP

Roche to Acquire CAR-T Cell Therapy Focused Poseida for $1.5B

Poseida Therapeutics to be acquired by Roche for $9.00 per share plus CVR

Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.

Carl Icahn Increases Stake in CVR Partners LP

Carl Icahn's Strategic Acquisition of CVR Partners LP Shares

Stocks to Watch: Super Micro Computer, Chicago Rivet & Machine

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CVR/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CVR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVR\",,,,,undefined,":{"symbol":"CVR","market":"US","secType":"STK","nameCN":"Chicago Rivet & Machine","latestPrice":12.39,"timestamp":1745956800000,"preClose":11.9167,"halted":0,"volume":9697,"hourTrading":{"tag":"盘后","latestPrice":12.39,"preClose":12.39,"latestTime":"16:05 EDT","volume":3,"amount":37.51,"timestamp":1745957108037},"delay":0,"floatShares":728384,"shares":966132,"eps":-5.81247,"marketStatus":"Not Yet Opened","change":0.4733,"latestTime":"04-29 16:00:00 EDT","open":11.8244,"high":13.8,"low":11.2838,"amount":121824.6969,"amplitude":0.211149,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.81247,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746000000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":11.9167,"dividendRate":0.020985,"postHourTrading":{"tag":"盘后","latestPrice":12.39,"preClose":12.39,"latestTime":"16:05 EDT","volume":3,"amount":37.51,"timestamp":1745957108037},"volumeRatio":1.552563},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVR\",,,,,undefined,":{"symbol":"CVR","floatShares":728384,"roa":"-12.45%","roe":"-24.42%","lyrEps":-5.81247,"volumeRatio":1.552563,"shares":966132,"dividePrice":0.26,"high":13.8,"amplitude":0.211149,"preClose":11.9167,"low":11.2838,"week52Low":8.25,"pbRate":"0.60","psRate":"0.44","week52High":22.27,"institutionHeld":0.1821,"latestPrice":12.39,"eps":-5.81247,"divideRate":0.020985,"volume":9697,"delay":0,"ttmEps":-5.81247,"open":11.8244,"prevYearClose":15.84,"prevWeekClose":10.2,"prevMonthClose":10.89,"prevQuarterClose":10.89,"fiveDayClose":9.06,"twentyDayClose":10.89,"sixtyDayClose":15.4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CVR\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2491307910","title":"Press Release: Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2491307910","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491307910?lang=en_us&edition=fundamental","pubTime":"2024-12-14 03:55","pubTimestamp":1734119700,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million. Palvella Therapeutics to debut on Nasdaq under the ticker symbol \"PVLA\" as a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage pipeline and a platform for treating serious, rare genetic diseases. Strong balance sheet with approximately $80.0 million of cash and cash equivalents, including proceeds from a PIPE financing co-led by BVF Partners, L.P. and Frazier Life Sciences. Cash expected to fund operations into the second half of 2027, including through Phase 3 SELVA clinical trial of QTORIN 3.9% rapamycin anhydrous gel  for the treatment of microcystic lymphatic malformations  and Phase 2 clinical trial in cutaneous venous malformations . QTORIN rapamycin has the potential to be the first approved therapy and standard of care in the U.S. for microcystic LMs and cutaneous VMs. Concurrent with the merger, Palvella completed","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVR","BK4099","BK4555","PIRS","BK4585","LENZ","03160","BK4139","BK4161","BK4588","TM"],"gpt_icon":0},{"id":"2491362324","title":"CVR Energy (CVI) Receives a Sell from Scotiabank","url":"https://stock-news.laohu8.com/highlight/detail?id=2491362324","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491362324?lang=en_us&edition=fundamental","pubTime":"2024-12-13 20:35","pubTimestamp":1734093357,"startTime":"0","endTime":"0","summary":"In a report released today, Paul Cheng from Scotiabank maintained a Sell rating on CVR Energy (CVI – Research Report), with a price target of $21.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cvr-energy-cvi-receives-a-sell-from-scotiabank-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cvr-energy-cvi-receives-a-sell-from-scotiabank-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4138","BK4161","CVR","CVI"],"gpt_icon":0},{"id":"2491347011","title":"CVR Energy Prices $325 Million Term Loan; Negotiating for Sale of Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2491347011","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491347011?lang=en_us&edition=fundamental","pubTime":"2024-12-13 18:20","pubTimestamp":1734085219,"startTime":"0","endTime":"0","summary":"CVR Energy  said late Thursday its subsidiaries have priced a proposed $325 million senior secured term loan B due 2027.The loan will be issued at a price equal to 99% of their face value and bear interest at the secured overnight financing rate plus 4.0%.The deal is expected to close before the end of the year.The company said it plans to use proceeds from the loan primarily for capital expenditures, including a planned turnaround at its Coffeyville refinery next year.The company also said it is negotiating the possible sale of its interests in one of its midstream assets for less than $100 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4138","BK4161","CVI","CVR"],"gpt_icon":0},{"id":"2491336688","title":"CVR Energy Announces New Executive Employment Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2491336688","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491336688?lang=en_us&edition=fundamental","pubTime":"2024-12-13 06:56","pubTimestamp":1734044164,"startTime":"0","endTime":"0","summary":"An update from CVR Partners ( ($UAN) ) is now available. CVR Energy has announced a new employment agreement for Mr. Lamp, effective January 1, 202...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cvr-energy-announces-new-executive-employment-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cvr-energy-announces-new-executive-employment-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVR","BK4161"],"gpt_icon":0},{"id":"2491936686","title":"CVR Energy’s Strategic Moves: Tender Offer and Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2491936686","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491936686?lang=en_us&edition=fundamental","pubTime":"2024-12-13 06:55","pubTimestamp":1734044115,"startTime":"0","endTime":"0","summary":"CVR Energy ( ($CVI) ) has shared an announcement. CVR Energy has entered into a Tender Offer Agreement with Icahn Enterprises to purchase a signifi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cvr-energys-strategic-moves-tender-offer-and-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cvr-energys-strategic-moves-tender-offer-and-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVR","BK4161"],"gpt_icon":0},{"id":"2491688173","title":"Press Release: CVR Energy Announces Pricing of Proposed Senior Secured Term Loan B Facility, 2025 Capital Expenditure Outlook, New Employment Agreement with Dave Lamp","url":"https://stock-news.laohu8.com/highlight/detail?id=2491688173","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491688173?lang=en_us&edition=fundamental","pubTime":"2024-12-13 06:14","pubTimestamp":1734041640,"startTime":"0","endTime":"0","summary":"SUGAR LAND, Texas, Dec. 12, 2024  -- CVR Energy, Inc.  today announced that certain of its wholly owned subsidiaries have priced a proposed $325 million aggregate principal amount senior secured term loan B due 2027 . The loans under the Facility will be issued at a price equal to 99% of their face value and bear interest at SOFR plus 4.0%, with closing expected before the end of the year. The proceeds of the loans under the Facility are expected to be used primarily for capital expenditures, including the planned 2025 turnaround at the Coffeyville refinery. The Company is also in negotiations for the potential sale of its interests in one of its midstream assets, with total consideration, if the transaction is finalized, approved and closed, expected to be under $100 million. Such sale, if any is consummated, is expected to further enhance the Company's liquidity position.The Company also published its capital expenditure outlook for 2025 set forth below, which for its Petroleum segme","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVI","CVR","BK4138","BK4161"],"gpt_icon":0},{"id":"2490859155","title":"NLS Pharmaceutics CEO Issues Letter to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2490859155","media":"ACCESSWIRE","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490859155?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:30","pubTimestamp":1733920200,"startTime":"0","endTime":"0","summary":"ZURICH, SWITZERLAND / ACCESSWIRE / December 11, 2024 / NLS Pharmaceutics Ltd.  , a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that its Chief Executive Officer, Alex Zwyer, has issued the following letter to shareholders:. As we move forward with exciting developments at NLS, I want to update you on the significant progress we've made, key challenges we've overcome, and the strategic opportunities that lie ahead-especially as we approach the expected closing of our transformative merger with Kadimastem Ltd. , an advanced clinical-stage company.Final top line results from the ongoing study are expected to be shared by the end of this year. In addition, the Company's broader development plans include exploring the application of its DOXA platform also in other neurodegenerative conditions, such as Amyotrophic Lateral Sclerosis .","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MYU32KppGNEDO6afIPEqHA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/05653921e1d228198a0d21d272ff6d19","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MYU32KppGNEDO6afIPEqHA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/05653921e1d228198a0d21d272ff6d19"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nls-pharmaceutics-ceo-issues-letter-123000170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NLSP","BK4161","BK4007","CVR","NLSPW"],"gpt_icon":1},{"id":"2489980239","title":"Icahn Enterprises launches public bid to boost stake in CVR Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2489980239","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489980239?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:49","pubTimestamp":1733496586,"startTime":"0","endTime":"0","summary":"Dec 6  - Billionaire activist Carl Icahn's investment firm Icahn Enterprises    unveiled a slightly sweetened public bid on Friday to boost its stake in refiner CVR Energy    to 84%.   CVR Energy shares rose nearly 4% in early morning trade.   Icahn Enterprises, which currently owns 66.3% of CVR shares, said it has commenced a cash tender offer to buy roughly 17.8 million additional shares in the refining firm at $18.25 per share.   The purchase price represents a slight discount to CVR's last close but is more than the offer Icahn Enterprises made last month to buy 15 million additional shares in the Texas-based refiner for $17.50 to increase its stake to 81.3%.   CVR Energy did not immediately respond to a request for comment.   The mildly enhanced offer comes at a time when refining margins have slumped, driven by sluggish demand and an expansion in global refining capacity.   CVR Energy operates a 115,000-barrel-per-day  Coffeyville refinery in Kansas and a 75,000-bpd Wynnewood fac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4138","BK4590","CVI","BK4206","CVR","BK4161","IEP"],"gpt_icon":0},{"id":"2489153236","title":"Icahn Enterprises' Latest Tender Offer Looks to Boost Its Stake in CVR Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2489153236","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489153236?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:36","pubTimestamp":1733495760,"startTime":"0","endTime":"0","summary":"Carl Icahn's investment firm continues to eye opportunities to increase its stake in CVR Energy.Icahn Enterprises commenced a cash tender offer for up to 17.8 million shares of CVR Energy's common stock at price of $18.25 a share. The latest offer would boost its stake in the small refiner to about 84% of its outstanding shares from its current position of about 66% if the tender offer is fully or over-subscribed.Icahn Enterprises is offering a nearly 11% premium over CVR's closing share price of $16.52 on Nov. 7.The tender offer is scheduled to expire near midnight on Jan. 6 unless extended.IEP in November proposed boosting its stake by more than 20% in CVR. The firm at the time offered to boost its holdings to more than 81% by buying up to 15 million additional shares, The Wall Street Journal reported.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IEP","BK4206","CVR","BK4161","CVI","BK4590","BK4138"],"gpt_icon":0},{"id":"2489278280","title":"Press Release: ICAHN ENTERPRISES L.P. AND ICAHN ENTERPRISES HOLDINGS L.P. ANNOUNCE COMMENCEMENT OF TENDER OFFER FOR UP TO 17,753,322 SHARES OF COMMON STOCK OF CVR ENERGY","url":"https://stock-news.laohu8.com/highlight/detail?id=2489278280","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489278280?lang=en_us&edition=fundamental","pubTime":"2024-12-06 21:30","pubTimestamp":1733491800,"startTime":"0","endTime":"0","summary":"ICAHN ENTERPRISES L.P. AND ICAHN ENTERPRISES HOLDINGS L.P. ANNOUNCE COMMENCEMENT OF TENDER OFFER FOR UP TO 17,753,322 SHARES OF COMMON STOCK OF CVR ENERGY. The tender offer is scheduled to expire at one minute after 11:59 P.M., New York City time, on January 6, 2025, unless the offer is extended.In connection with the tender offer, IEP, IEH and certain of its affiliates have entered into a Tender Offer Agreement, pursuant to which IEH has agreed to commence the tender offer on the terms described herein and in the Offer to Purchase, and the Special Committee -- Strategic of CVR Energy, which is comprised of independent directors of CVR Energy who are not affiliated with IEP or IEH, acting upon the express delegation of authority by the CVR Energy Board of Directors, has unanimously determined to express no opinion and","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2041044095.USD","BK4008","A","BK4121","IEP","CVI","LU2092937221.SGD","LU2413666699.HKD","BK4567","LU1165135440.EUR","BK4024","B","LU0347712357.USD","LU1721428933.USD","FOR","CVR","BK4206","BK4585","LU2413666426.HKD","BK4138","BK4161","LU1543694498.USD","BK4590","UP","BK4588"],"gpt_icon":0},{"id":"2489646104","title":"Coloplast A/S - Decisions at the Annual General Meeting 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2489646104","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489646104?lang=en_us&edition=fundamental","pubTime":"2024-12-06 00:11","pubTimestamp":1733415060,"startTime":"0","endTime":"0","summary":"Today, 5 December 2024, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted:. The annual report for the financial year 2023/24 was approved.Distribution of year-end dividend of DKK 17.00 per share of nominally DKK 1 was approved. In addition to the interim dividend of DKK 5.00 per share of nominally DKK 1 paid out in connection with Coloplast A/S’ half- year result, this brings the total dividend paid for the financial year 2023/24 to DKK 22.00 per share of nominally DKK 1.The remuneration report for the financial year 2023/24 was approved.The remuneration of the members of the Board of Directors for the financial year 2024/25 was approved.Lars Sren Rasmussen, Niels Peter Louis-Hansen, Annette Brüls, Carsten Hellmann, Jette Nygaard-Andersen and Marianne Wiinholt were re-elected to the Board of Directors.Authorisation was granted to the chairman of the Annual General Meeting to make certain registrations with the Danish Business Authority and o","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vtOyV58KsIYMzqeBgs6Kag--~B/aD0xMTgyO3c9MjQ3MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/133f9853fa5e77f27e2587159807b598","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vtOyV58KsIYMzqeBgs6Kag--~B/aD0xMTgyO3c9MjQ3MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/133f9853fa5e77f27e2587159807b598"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coloplast-decisions-annual-general-meeting-161100115.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4198","CVR","CLPBY","CLPBF","BK4161"],"gpt_icon":0},{"id":"2488954151","title":"The Zacks Analyst Blog Highlights Roche, Poseida Therapeutics, Merck, AstraZeneca and Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2488954151","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488954151?lang=en_us&edition=fundamental","pubTime":"2024-12-02 18:00","pubTimestamp":1733133600,"startTime":"0","endTime":"0","summary":"Chicago, IL – December 2, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Roche RHHBY, Poseida Therapeutics PSTX, Merck MRK, AstraZeneca AZN and Novartis NVS.This week, Roche announced that it will acquire its existing partner, Poseida Therapeutics for $9 per share in cash, representing a total equity value of approximately $1.0 billion. Merck and AstraZeneca’s late-stage studies, evaluating the expanded use of their new drugs, met their respective goals. The European Commission approved Novartis’ breast cancer drug Kisqali  for a broad population in early breast cancer.Based on the overwhelming efficacy seen in the study, an independent data monitoring committee  recommended the study be stopped early. The DMC also recommended that patients with this advanced form of PAH be offered the oppo","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/6pmiwRZRhtc7hxDNA3zxVQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/6pmiwRZRhtc7hxDNA3zxVQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-roche-100000082.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1291159041.SGD","MRK","RHHBY","IE00BJT1NW94.SGD","LU0203347892.USD","SG9999014567.USD","FC","EC","SGXZ57979304.SGD","IE00B2B36J28.USD","LU1829250122.USD","SG9999002232.USD","BK4588","BK4201","AZN","BK4161","LU1061106388.HKD","SG9999001176.SGD","BK4211","IE00BFTCPJ56.SGD","MBC","LU1934455863.HKD","LU1430594728.SGD","PSTX","EBC","LU1585245621.USD","LU1037948897.HKD","LU2089984988.USD","LU1037948541.HKD","LU0965509101.SGD","IE00BN8TJ469.HKD","BK4123","LU1057294990.SGD","03165","BK4139","CVR","LU2112291526.USD","LU0965508806.USD","LU2023250843.SGD","IE000M9KFDE8.USD","LU0208291251.USD","LU0109394709.USD","LU0965509010.AUD","LU2106854487.HKD","SG9999014559.SGD","LU1066051498.USD","NVS","LU0203345920.USD","LENZ","ADT"],"gpt_icon":1},{"id":"2487151878","title":"Pharma Stock Roundup: RHHBY to Buy PSTX, MRK, AZN See Pipeline Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2487151878","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487151878?lang=en_us&edition=fundamental","pubTime":"2024-11-30 04:00","pubTimestamp":1732910400,"startTime":"0","endTime":"0","summary":"Roche announced plans to acquire Poseida Therapeutics for about $1 billion.Merck, AstraZeneca and Novartis have all seen success in studies of new drugs in their pipelines.This week, Roche RHHBY announced that it will acquire its existing partner, Poseida Therapeutics PSTX for $9 per share in cash, representing a total equity value of approximately $1.0 billion. Merck MRK and AstraZeneca’s AZN late-stage studies, evaluating the expanded use of their new drugs, met their respective goals. The European Commission approved Novartis’ NVS breast cancer drug Kisqali  for a broad population in early breast cancer.Based on the overwhelming efficacy seen in the study, an independent data monitoring committee  recommended the study be stopped early. The DMC also recommended that patients with this advanced form of PAH be offered the opportunity to get Winrevair through an open-label extension study.Roche announced a definitive agreement to acquire Poseida Therapeutics, a biotech making allogenei","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/VTpWEp9iphTX3xsYcMogbg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/VTpWEp9iphTX3xsYcMogbg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-rhhby-buy-200000767.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BJT1NW94.SGD","LU0208291251.USD","LU1934455194.USD","MBC","LU1989772923.USD","LU0320765489.SGD","NVS","SG9999001440.SGD","LU2468319806.SGD","BK4585","BK4139","CVR","BK4201","LU1037948541.HKD","LU1934455277.USD","SG9999001176.SGD","MRK","FC","LU1116320901.HKD","SG9999002232.USD","RHHBY","03165","LU0058720904.USD","LU0289739699.SGD","EC","LU1093756168.USD","LU1023059063.AUD","LU2089984988.USD","LU2417539215.USD","BK4534","SG9999014567.USD","LU0320765992.SGD","IE00BBT3K403.USD","BK4559","ADT","PSTX","BK4086","EBC","LU0238689110.USD","IE0009355771.USD","LU2112291526.USD","LU1934455863.HKD","LU0965509101.SGD","LU0889565916.HKD","LU2361044949.HKD","LU0070302665.USD","AZN","SGXZ57979304.SGD","LU0122379950.USD","IE00BJJMRZ35.SGD"],"gpt_icon":1},{"id":"2486891569","title":"Carl Icahn Increases Stake in CVR Partners LP","url":"https://stock-news.laohu8.com/highlight/detail?id=2486891569","media":"GuruFocus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486891569?lang=en_us&edition=fundamental","pubTime":"2024-11-27 11:33","pubTimestamp":1732678390,"startTime":"0","endTime":"0","summary":"On November 26, 2024, Carl Icahn (Trades, Portfolio), a prominent activist investor, executed a strategic stock transaction involving CVR Partners LP. This transaction saw the addition of 25,815 share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2617098/carl-icahn-increases-stake-in-cvr-partners-lp","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["CVR","UAN","BK4161","BK4590","BK4093"],"gpt_icon":0},{"id":"2486884715","title":"Roche to Acquire CAR-T Cell Therapy Focused Poseida for $1.5B","url":"https://stock-news.laohu8.com/highlight/detail?id=2486884715","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486884715?lang=en_us&edition=fundamental","pubTime":"2024-11-26 23:59","pubTimestamp":1732636740,"startTime":"0","endTime":"0","summary":"Shares of PSTX are up in pre-market trading on the acquisition news.Roche’s shares have lost 1.6% year to date against the industry’s growth of 6.4%.Per the terms, Roche will initiate a tender offer to acquire all of the outstanding shares of Poseida common stock for $9.00 per share in cash. PSTX’s stockholders would also receive a non-tradeable contingent value right  for up to an aggregate of $4.00 per share in cash, representing a total deal value of up to approximately $1.5 billion.The offer price of $9 represents a premium of approximately 215% to Poseida’s closing share price on Nov. 25, 2024.California-based Poseida’s R&D portfolio includes pre-clinical and clinical-stage off-the-shelf  CAR-T therapies across several therapeutic areas, including hematological malignancies, solid tumors and autoimmune disease, as well as manufacturing capabilities and technology platforms.Roche is currently looking to augment its pipeline after facing a few pipeline setbacks a couple of years ago","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9DYdttPy00EKBHhcxtlCA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9DYdttPy00EKBHhcxtlCA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/roche-acquire-car-t-cell-155900367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CVR","LU1894683348.USD","SG9999001176.SGD","BK4161","GILD","IE000M9KFDE8.USD","PSTX","LU0985481810.HKD","LU0306806265.USD","LU0321505439.SGD","LU2087621335.USD","CAR","IE00BSNM7G36.USD","BK4578","LU1057294990.SGD","LU1066051498.USD","SG9999013999.USD","BK4568","LU1066053197.SGD","PFE","BK4583","LU0170899867.USD","LU0889565916.HKD","IE00BBT3K403.USD","LU0122379950.USD","03165","LU0234572021.USD","BK4534","BK4592","SG9999002232.USD","LU1571399168.USD","BK4533","SG9999003800.SGD","LU0289739699.SGD","IE0002270589.USD","IE00BLSP4239.USD","LU0058720904.USD","RHHBY","BK4532","IE00B19Z3581.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU1023059063.AUD","LU0225771236.USD","LU0109394709.USD","BK4007","LU0320765992.SGD","SG9999002224.SGD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2486020823","title":"Poseida Therapeutics to be acquired by Roche for $9.00 per share plus CVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2486020823","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486020823?lang=en_us&edition=fundamental","pubTime":"2024-11-26 18:25","pubTimestamp":1732616716,"startTime":"0","endTime":"0","summary":"Poseida Therapeutics (PSTX) announced that it has entered into a merger agreement to be acquired by Roche (RHHBY) at a price of $9.00 per share in ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/poseida-therapeutics-to-be-acquired-by-roche-for-9-00-per-share-plus-cvr?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/poseida-therapeutics-to-be-acquired-by-roche-for-9-00-per-share-plus-cvr?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSTX","RHHBY","03165","LENZ","BK4007","BK4161","BK4139","CVR"],"gpt_icon":0},{"id":"2486043218","title":"Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2486043218","media":"PR Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486043218?lang=en_us&edition=fundamental","pubTime":"2024-11-26 14:10","pubTimestamp":1732601400,"startTime":"0","endTime":"0","summary":"Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right  to receive up to an aggregate of $4.00 per share in cash; transaction represents total equity value of up to $1.5 billion. Poseida to join the Roche Group and advance its innovative pipeline of non-viral, TSCM-rich CAR-T therapies and genetic medicines as part of Roche's Pharmaceuticals Division. \"Poseida has demonstrated the unique ability of its proprietary non-viral technology platform to create allogeneic, TSCM-rich CAR-T therapies with the potential to improve clinical outcomes and expand access to this important class of medicines. Most recently, this was highlighted by the compelling interim clinical data for P-BCMA-ALLO1 in patients with multiple myeloma,\" saidKristin Yarema, Ph.D., President and Chief Executive Officer ofPoseida Therapeutics. \"We have worked closely with Roche through our collaboration focused on hematologi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0ZbecZcTygdfn10jwwgw3w--~B/aD0yOTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/4f05f1549db26db37f15a45f2f462010","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0ZbecZcTygdfn10jwwgw3w--~B/aD0yOTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/4f05f1549db26db37f15a45f2f462010"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/poseida-therapeutics-inc-announces-agreement-061000051.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/poseida-therapeutics-inc-announces-agreement-061000051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CAR","PSTX","CVR","BK4161","BK4230","BK4139","BK4022"],"gpt_icon":0},{"id":"2485002264","title":"Carl Icahn Increases Stake in CVR Partners LP","url":"https://stock-news.laohu8.com/highlight/detail?id=2485002264","media":"GuruFocus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485002264?lang=en_us&edition=fundamental","pubTime":"2024-11-22 11:35","pubTimestamp":1732246549,"startTime":"0","endTime":"0","summary":"On November 21, 2024, Carl Icahn (Trades, Portfolio), a prominent activist investor, executed a significant stock transaction involving CVR Partners LP. The transaction saw the addition of 19,174 shar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2613081/carl-icahn-increases-stake-in-cvr-partners-lp","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["BK4161","ROE","CVR","BK4093","UAN","BK4590"],"gpt_icon":0},{"id":"2484138918","title":"Carl Icahn's Strategic Acquisition of CVR Partners LP Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2484138918","media":"GuruFocus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484138918?lang=en_us&edition=fundamental","pubTime":"2024-11-20 08:15","pubTimestamp":1732061758,"startTime":"0","endTime":"0","summary":"On November 18, 2024, renowned activist investor Carl Icahn (Trades, Portfolio) made a significant addition to the portfolio by acquiring 13,971 shares of CVR Partners LP (UAN, Financial) at a transac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2610108/carl-icahns-strategic-acquisition-of-cvr-partners-lp-shares","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["CVR","BK4590","BK4161","BK4093","UAN"],"gpt_icon":0},{"id":"2484936105","title":"Stocks to Watch: Super Micro Computer, Chicago Rivet & Machine","url":"https://stock-news.laohu8.com/highlight/detail?id=2484936105","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484936105?lang=en_us&edition=fundamental","pubTime":"2024-11-19 07:48","pubTimestamp":1731973680,"startTime":"0","endTime":"0","summary":"Super Micro Computer has submitted a plan to maintain its listing on the Nasdaq after it missed deadlines for providing financial reports to investors. The server maker said it intends to regain compliance with the exchange's continued listing requirements after failing to file its reports for its fiscal year ended June 30, and for the first quarter of fiscal 2025 in a timely manner. The data-center specialist had until Monday to file a plan to regain compliance. Shares surge 34%, to $28.95, in after-hours trading.Chicago Rivet & Machine slashed its quarterly dividend to three cents from 10 cents, citing macroeconomic headwinds that are weighing on its performance. The company, which manufactures and sells rivets and specialty cold-formed parts, noted a significant reduction in demand from its automotive customers. Its board determined that cutting the dividend was necessary given the recent operating performance. Shares fall 5.9%, to $17, in postmarket trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVR","BK4170","BK4161","LU0053671581.USD","BK4585","LU1861215975.USD","BK4588","LU1861220033.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":6,"totalSize":147,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CVR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-28","symbol":"CVR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743134400000,"reportTimeType":"post","actualEps":-3.74},{"date":"2025-03-05","symbol":"CVR","amount":0.03,"announcedDate":"2025-02-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-05","defaultRemindTime":1741185000000,"name":"芝加哥机械","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-03-05","currency":"USD","dateTimestamp":1741150800000,"payDate":"2025-03-20"},{"date":"2024-12-05","symbol":"CVR","amount":0.03,"announcedDate":"2024-11-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-05","defaultRemindTime":1733409000000,"name":"芝加哥机械","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-05","currency":"USD","dateTimestamp":1733374800000,"payDate":"2024-12-20"},{"market":"US","date":"2024-11-12","symbol":"CVR","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-1.5},{"date":"2024-09-05","symbol":"CVR","amount":0.1,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-05","defaultRemindTime":1725543000000,"name":"芝加哥机械","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-20","payableDate":"2024-09-05","currency":"USD","dateTimestamp":1725508800000,"payDate":"2024-09-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CVR\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-03","recordDate":"2015-06-05","paymentDate":"2015-06-19","value":0.18,"currency":"USD"},{"executeDate":"2015-09-02","recordDate":"2015-09-05","paymentDate":"2015-09-18","value":0.18,"currency":"USD"},{"executeDate":"2015-12-02","recordDate":"2015-12-04","paymentDate":"2015-12-18","value":0.18,"currency":"USD"},{"executeDate":"2016-03-02","recordDate":"2016-03-04","paymentDate":"2016-03-18","value":0.43,"currency":"USD"},{"executeDate":"2016-06-01","recordDate":"2016-06-03","paymentDate":"2016-06-20","value":0.18,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CVR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CVR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CVR","date":"2025-04-28","current":-1.754847,"percent":0.396916,"low":-39.938266,"twenty":-4.329548,"median":10.103888,"eighty":31.140207,"high":512.74894,"avg":24.00774,"sd":82.482986,"marketCap":9854546},"quantilePoints":[{"date":"2020-05-01","current":36.361369,"twenty":11.492773,"median":14.340289,"eighty":21.460787,"marketCap":19573834},{"date":"2020-05-08","current":64.609528,"twenty":11.533322,"median":14.350757,"eighty":21.593261,"marketCap":19902319},{"date":"2020-05-15","current":60.72041,"twenty":11.75111,"median":14.387392,"eighty":21.713547,"marketCap":18704315},{"date":"2020-05-22","current":63.072698,"twenty":11.879348,"median":14.437113,"eighty":21.851795,"marketCap":19428914},{"date":"2020-05-29","current":61.535869,"twenty":11.925972,"median":14.45543,"eighty":21.955005,"marketCap":18955509},{"date":"2020-06-05","current":69.000467,"twenty":11.953593,"median":14.491594,"eighty":21.993008,"marketCap":21254904},{"date":"2020-06-12","current":68.725091,"twenty":11.971412,"median":14.51279,"eighty":22.096254,"marketCap":21170077},{"date":"2020-06-19","current":64.170432,"twenty":12.003091,"median":14.524165,"eighty":22.145753,"marketCap":19767060},{"date":"2020-06-26","current":65.236804,"twenty":12.045661,"median":14.563454,"eighty":22.22747,"marketCap":20095545},{"date":"2020-07-02","current":65.236804,"twenty":12.070993,"median":14.572729,"eighty":22.278604,"marketCap":20095545},{"date":"2020-07-10","current":68.655464,"twenty":12.102085,"median":14.618222,"eighty":22.328291,"marketCap":21148629},{"date":"2020-07-17","current":65.393624,"twenty":12.103987,"median":14.639187,"eighty":22.417772,"marketCap":20143852},{"date":"2020-07-24","current":64.609528,"twenty":12.156,"median":14.65566,"eighty":22.450708,"marketCap":19902319},{"date":"2020-07-31","current":65.581808,"twenty":12.195463,"median":14.726343,"eighty":22.477016,"marketCap":20201820},{"date":"2020-08-07","current":-28.941168,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":20288772},{"date":"2020-08-14","current":-28.265874,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":19815367},{"date":"2020-08-21","current":-27.425201,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":19226026},{"date":"2020-08-28","current":-28.293436,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":19834689},{"date":"2020-09-04","current":-27.563018,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":19322640},{"date":"2020-09-11","current":-27.921336,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":19573834},{"date":"2020-09-18","current":-29.423521,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":20626918},{"date":"2020-09-25","current":-30.23663,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":21196936},{"date":"2020-10-02","current":-29.768059,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":20868451},{"date":"2020-10-09","current":-28.527723,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":19998932},{"date":"2020-10-16","current":-29.44378,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":20641120},{"date":"2020-10-23","current":-28.94103,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":20288675},{"date":"2020-10-30","current":-28.913605,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":20269449},{"date":"2020-11-06","current":-29.248927,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":20699378},{"date":"2020-11-13","current":-28.619853,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":20254184},{"date":"2020-11-20","current":-29.598411,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":20946707},{"date":"2020-11-27","current":-29.001147,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":20524025},{"date":"2020-12-04","current":-30.441682,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":21543487},{"date":"2020-12-11","current":-31.910886,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":22583238},{"date":"2020-12-18","current":-32.231839,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":22810376},{"date":"2020-12-24","current":-32.250132,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":22823322},{"date":"2020-12-31","current":-31.207956,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":22085777},{"date":"2021-01-08","current":-31.317171,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":22163068},{"date":"2021-01-15","current":-31.330822,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":22172729},{"date":"2021-01-22","current":-32.939957,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":23311509},{"date":"2021-01-29","current":-37.313029,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":26406319},{"date":"2021-02-05","current":-35.494614,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":25119432},{"date":"2021-02-12","current":-35.494614,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":25119432},{"date":"2021-02-19","current":-36.013381,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":25486562},{"date":"2021-02-26","current":-37.822242,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":26766687},{"date":"2021-03-05","current":-37.201086,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":26327097},{"date":"2021-03-12","current":-38.375138,"twenty":12.207724,"median":14.779919,"eighty":22.518565,"marketCap":27157970},{"date":"2021-03-19","current":512.74894,"twenty":12.207724,"median":14.785153,"eighty":22.519587,"marketCap":25868184},{"date":"2021-03-26","current":492.162379,"twenty":12.21521,"median":14.810498,"eighty":22.566782,"marketCap":24829592},{"date":"2021-04-01","current":496.94995,"twenty":12.230259,"median":14.838116,"eighty":22.612735,"marketCap":25071125},{"date":"2021-04-09","current":456.925847,"twenty":12.249155,"median":14.969052,"eighty":22.647212,"marketCap":23051909},{"date":"2021-04-16","current":477.799663,"twenty":12.278361,"median":15.005921,"eighty":22.675789,"marketCap":24104993},{"date":"2021-04-23","current":486.800297,"twenty":12.309766,"median":15.041765,"eighty":22.708211,"marketCap":24559075},{"date":"2021-04-30","current":495.992428,"twenty":12.326543,"median":15.05745,"eighty":22.745362,"marketCap":25022818},{"date":"2021-05-07","current":47.364909,"twenty":12.328109,"median":15.090597,"eighty":22.761485,"marketCap":25293335},{"date":"2021-05-14","current":48.739904,"twenty":12.328109,"median":15.147795,"eighty":22.784498,"marketCap":26027596},{"date":"2021-05-21","current":48.649443,"twenty":12.328109,"median":15.264008,"eighty":22.837222,"marketCap":25979289},{"date":"2021-05-28","current":47.45537,"twenty":12.328109,"median":15.285623,"eighty":22.929929,"marketCap":25341642},{"date":"2021-06-04","current":46.863036,"twenty":12.328109,"median":15.318864,"eighty":22.956241,"marketCap":25025330},{"date":"2021-06-11","current":47.003069,"twenty":12.328109,"median":15.491188,"eighty":22.972736,"marketCap":25100109},{"date":"2021-06-18","current":47.039254,"twenty":12.328109,"median":15.763268,"eighty":22.987892,"marketCap":25119432},{"date":"2021-06-25","current":47.256357,"twenty":12.328109,"median":15.867833,"eighty":23.062262,"marketCap":25235367},{"date":"2021-07-02","current":47.401094,"twenty":12.328109,"median":16.100049,"eighty":23.127983,"marketCap":25312658},{"date":"2021-07-09","current":46.966885,"twenty":12.328109,"median":16.336166,"eighty":23.215605,"marketCap":25080786},{"date":"2021-07-16","current":48.323786,"twenty":12.328109,"median":16.354508,"eighty":23.33229,"marketCap":25805385},{"date":"2021-07-23","current":48.649443,"twenty":12.328109,"median":16.507354,"eighty":23.367342,"marketCap":25979289},{"date":"2021-07-30","current":48.757995,"twenty":12.328109,"median":16.5314,"eighty":23.433357,"marketCap":26037257},{"date":"2021-08-06","current":48.197142,"twenty":12.328109,"median":16.751907,"eighty":23.473758,"marketCap":25737756},{"date":"2021-08-13","current":15.677882,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":25602498},{"date":"2021-08-20","current":15.624636,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":25515546},{"date":"2021-08-27","current":15.234168,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":24877899},{"date":"2021-09-03","current":15.630552,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":25525207},{"date":"2021-09-10","current":15.500396,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":25312658},{"date":"2021-09-17","current":15.529977,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":25360965},{"date":"2021-09-24","current":15.997355,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":26124209},{"date":"2021-10-01","current":15.330838,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":25035764},{"date":"2021-10-08","current":15.441234,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":25216045},{"date":"2021-10-15","current":15.29333,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":24974512},{"date":"2021-10-22","current":15.879031,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":25930982},{"date":"2021-10-29","current":15.914528,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":25988950},{"date":"2021-11-05","current":15.961858,"twenty":12.328109,"median":16.757512,"eighty":23.492866,"marketCap":26066241},{"date":"2021-11-12","current":19.05722,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":28520216},{"date":"2021-11-19","current":17.043042,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":25505884},{"date":"2021-11-26","current":16.784815,"twenty":12.328109,"median":16.764134,"eighty":23.492866,"marketCap":25119432},{"date":"2021-12-03","current":16.64918,"twenty":12.328109,"median":16.720257,"eighty":23.492866,"marketCap":24916447},{"date":"2021-12-10","current":16.707346,"twenty":12.328109,"median":16.578232,"eighty":23.492866,"marketCap":25003496},{"date":"2021-12-17","current":16.368422,"twenty":12.328109,"median":16.507354,"eighty":23.492866,"marketCap":24496276},{"date":"2021-12-23","current":17.194751,"twenty":12.328109,"median":16.507354,"eighty":23.492866,"marketCap":25732925},{"date":"2021-12-31","current":16.962346,"twenty":12.328109,"median":16.507354,"eighty":23.492866,"marketCap":25385118},{"date":"2022-01-07","current":17.223802,"twenty":12.328109,"median":16.51041,"eighty":23.477193,"marketCap":25776401},{"date":"2022-01-14","current":16.597599,"twenty":12.328109,"median":16.51041,"eighty":23.455995,"marketCap":24839253},{"date":"2022-01-21","current":16.662156,"twenty":12.328109,"median":16.507354,"eighty":23.409826,"marketCap":24935866},{"date":"2022-01-28","current":16.784815,"twenty":12.328109,"median":16.507354,"eighty":23.352506,"marketCap":25119432},{"date":"2022-02-04","current":17.575637,"twenty":12.328109,"median":16.507354,"eighty":23.215276,"marketCap":26302943},{"date":"2022-02-11","current":17.60146,"twenty":12.328109,"median":16.507354,"eighty":23.12348,"marketCap":26341588},{"date":"2022-02-18","current":17.669245,"twenty":12.328109,"median":16.507354,"eighty":23.110045,"marketCap":26443032},{"date":"2022-02-25","current":17.695068,"twenty":12.328109,"median":16.507354,"eighty":23.110045,"marketCap":26481678},{"date":"2022-03-04","current":16.842786,"twenty":12.328109,"median":16.507354,"eighty":23.029447,"marketCap":25206190},{"date":"2022-03-11","current":17.25608,"twenty":12.328109,"median":16.507354,"eighty":22.988472,"marketCap":25824708},{"date":"2022-03-18","current":18.721524,"twenty":12.328109,"median":16.507354,"eighty":22.987875,"marketCap":28017828},{"date":"2022-03-25","current":24.092736,"twenty":12.328109,"median":16.507354,"eighty":22.987875,"marketCap":26826587},{"date":"2022-04-01","current":22.930658,"twenty":12.328109,"median":16.507354,"eighty":22.987858,"marketCap":25532646},{"date":"2022-04-08","current":22.509055,"twenty":12.328109,"median":16.507354,"eighty":22.987858,"marketCap":25063203},{"date":"2022-04-14","current":22.844325,"twenty":12.328109,"median":16.507354,"eighty":22.987858,"marketCap":25436516},{"date":"2022-04-22","current":22.559554,"twenty":12.328109,"median":16.507354,"eighty":22.987858,"marketCap":25119432},{"date":"2022-04-29","current":22.637644,"twenty":12.328109,"median":16.507354,"eighty":22.976619,"marketCap":25206383},{"date":"2022-05-06","current":24.325458,"twenty":12.328109,"median":16.507354,"eighty":22.987858,"marketCap":24827949},{"date":"2022-05-13","current":25.604949,"twenty":12.328109,"median":16.507354,"eighty":23.089607,"marketCap":26133870},{"date":"2022-05-20","current":25.148224,"twenty":12.328109,"median":16.507354,"eighty":23.212533,"marketCap":25667711},{"date":"2022-05-27","current":25.164317,"twenty":12.328109,"median":16.507354,"eighty":23.35064,"marketCap":25684136},{"date":"2022-06-03","current":26.153965,"twenty":12.328109,"median":16.507354,"eighty":23.407381,"marketCap":26694227},{"date":"2022-06-10","current":26.968022,"twenty":12.328109,"median":16.507354,"eighty":23.442032,"marketCap":27525100},{"date":"2022-06-17","current":27.393983,"twenty":12.328109,"median":16.507354,"eighty":23.572201,"marketCap":27959860},{"date":"2022-06-24","current":26.977393,"twenty":12.328109,"median":16.507354,"eighty":23.702039,"marketCap":27534665},{"date":"2022-07-01","current":26.968022,"twenty":12.328109,"median":16.507354,"eighty":24.093339,"marketCap":27525100},{"date":"2022-07-08","current":26.835501,"twenty":12.328109,"median":16.507354,"eighty":24.239192,"marketCap":27389842},{"date":"2022-07-15","current":26.768673,"twenty":12.328109,"median":16.507354,"eighty":24.356214,"marketCap":27321633},{"date":"2022-07-22","current":26.58939,"twenty":12.328109,"median":16.507354,"eighty":24.574469,"marketCap":27138647},{"date":"2022-07-29","current":26.504199,"twenty":12.328109,"median":16.507354,"eighty":25.152957,"marketCap":27051696},{"date":"2022-08-05","current":31.213696,"twenty":12.328109,"median":16.507354,"eighty":25.226033,"marketCap":26689396},{"date":"2022-08-12","current":29.942551,"twenty":12.328109,"median":16.513467,"eighty":25.48284,"marketCap":25602498},{"date":"2022-08-19","current":31.072459,"twenty":12.328109,"median":16.591144,"eighty":25.883243,"marketCap":26568630},{"date":"2022-08-26","current":31.027826,"twenty":12.328109,"median":16.6557,"eighty":26.180431,"marketCap":26530467},{"date":"2022-09-02","current":30.563999,"twenty":12.328109,"median":16.746145,"eighty":26.42321,"marketCap":26133870},{"date":"2022-09-09","current":29.874756,"twenty":12.328109,"median":16.778359,"eighty":26.513664,"marketCap":25544530},{"date":"2022-09-16","current":30.31542,"twenty":12.328109,"median":16.784815,"eighty":26.682098,"marketCap":25921321},{"date":"2022-09-23","current":28.812643,"twenty":12.328109,"median":16.813045,"eighty":26.772686,"marketCap":24636366},{"date":"2022-09-30","current":29.117718,"twenty":12.328109,"median":16.913928,"eighty":26.965145,"marketCap":24897221},{"date":"2022-10-07","current":29.784363,"twenty":12.328109,"median":16.935322,"eighty":26.977393,"marketCap":25467239},{"date":"2022-10-14","current":28.872527,"twenty":12.328109,"median":16.962346,"eighty":27.157338,"marketCap":24687570},{"date":"2022-10-21","current":29.45669,"twenty":12.328109,"median":16.978485,"eighty":28.170626,"marketCap":25187061},{"date":"2022-10-28","current":31.693907,"twenty":12.328109,"median":17.006672,"eighty":28.872527,"marketCap":27100002},{"date":"2022-11-04","current":31.614814,"twenty":12.328109,"median":17.056031,"eighty":29.192291,"marketCap":27032373},{"date":"2022-11-11","current":6.227837,"twenty":12.326543,"median":17.057598,"eighty":29.289102,"marketCap":26539646},{"date":"2022-11-18","current":6.088997,"twenty":12.305809,"median":17.057598,"eighty":29.289102,"marketCap":25947986},{"date":"2022-11-25","current":6.007924,"twenty":12.269147,"median":17.057598,"eighty":29.289102,"marketCap":25602498},{"date":"2022-12-02","current":6.094098,"twenty":12.247957,"median":17.057598,"eighty":29.289102,"marketCap":25969724},{"date":"2022-12-09","current":6.17796,"twenty":12.230251,"median":17.057598,"eighty":29.289102,"marketCap":26327097},{"date":"2022-12-16","current":6.234638,"twenty":12.207724,"median":17.057598,"eighty":29.289102,"marketCap":26568630},{"date":"2022-12-23","current":6.461352,"twenty":12.200085,"median":17.057598,"eighty":29.289102,"marketCap":27534762},{"date":"2022-12-30","current":6.490825,"twenty":12.174894,"median":17.057598,"eighty":29.289102,"marketCap":27660359},{"date":"2023-01-06","current":6.554305,"twenty":12.123032,"median":17.043042,"eighty":29.289102,"marketCap":27930876},{"date":"2023-01-13","current":6.631365,"twenty":12.090799,"median":17.008688,"eighty":29.289102,"marketCap":28259264},{"date":"2023-01-20","current":6.601915,"twenty":12.045661,"median":16.978485,"eighty":29.289102,"marketCap":28133763},{"date":"2023-01-27","current":6.801401,"twenty":11.96805,"median":16.962346,"eighty":29.289102,"marketCap":28983863},{"date":"2023-02-03","current":6.685799,"twenty":11.652607,"median":16.929208,"eighty":29.289102,"marketCap":28491232},{"date":"2023-02-10","current":6.540679,"twenty":11.380574,"median":16.842786,"eighty":29.289102,"marketCap":27872811},{"date":"2023-02-17","current":6.563374,"twenty":11.327599,"median":16.794704,"eighty":29.289102,"marketCap":27969521},{"date":"2023-02-24","current":6.549771,"twenty":11.267484,"median":16.784815,"eighty":29.289102,"marketCap":27911553},{"date":"2023-03-03","current":6.864903,"twenty":11.18143,"median":16.764134,"eighty":29.289102,"marketCap":29254476},{"date":"2023-03-10","current":6.586045,"twenty":11.048334,"median":16.720257,"eighty":29.289102,"marketCap":28066134},{"date":"2023-03-17","current":6.579243,"twenty":10.986498,"median":16.623422,"eighty":29.289102,"marketCap":28037150},{"date":"2023-03-24","current":6.767416,"twenty":10.925029,"median":16.604055,"eighty":29.289102,"marketCap":28839040},{"date":"2023-03-31","current":10.012956,"twenty":10.185454,"median":16.600827,"eighty":29.288153,"marketCap":28713443},{"date":"2023-04-06","current":9.396411,"twenty":9.457055,"median":16.600827,"eighty":29.288153,"marketCap":26945421},{"date":"2023-04-14","current":10.103888,"twenty":9.354634,"median":16.604055,"eighty":29.289102,"marketCap":28974202},{"date":"2023-04-21","current":10.107291,"twenty":9.354634,"median":16.604055,"eighty":29.289102,"marketCap":28983960},{"date":"2023-04-28","current":9.937151,"twenty":9.354634,"median":16.604055,"eighty":29.289102,"marketCap":28496063},{"date":"2023-05-05","current":8.763021,"twenty":9.291969,"median":16.604055,"eighty":29.289102,"marketCap":25129093},{"date":"2023-05-12","current":12.88664,"twenty":9.281188,"median":16.604055,"eighty":29.289102,"marketCap":23675064},{"date":"2023-05-19","current":13.249496,"twenty":9.281188,"median":16.604055,"eighty":29.289102,"marketCap":24341695},{"date":"2023-05-26","current":12.894528,"twenty":9.281188,"median":16.604055,"eighty":29.289102,"marketCap":23689556},{"date":"2023-06-02","current":12.884011,"twenty":9.281188,"median":16.604055,"eighty":29.289102,"marketCap":23670234},{"date":"2023-06-09","current":13.420406,"twenty":9.281188,"median":16.604055,"eighty":29.289102,"marketCap":24655688},{"date":"2023-06-16","current":13.672828,"twenty":9.281188,"median":16.604055,"eighty":29.289102,"marketCap":25119432},{"date":"2023-06-23","current":13.730674,"twenty":9.275797,"median":16.613739,"eighty":29.290052,"marketCap":25225706},{"date":"2023-06-30","current":13.667569,"twenty":9.270407,"median":16.623422,"eighty":29.291001,"marketCap":25109770},{"date":"2023-07-07","current":13.14695,"twenty":9.270407,"median":16.623422,"eighty":29.291001,"marketCap":24153300},{"date":"2023-07-14","current":13.089103,"twenty":9.270407,"median":16.623422,"eighty":29.291001,"marketCap":24047025},{"date":"2023-07-21","current":13.462476,"twenty":9.270407,"median":16.623422,"eighty":29.291001,"marketCap":24732979},{"date":"2023-07-28","current":13.138535,"twenty":9.270407,"median":16.623422,"eighty":29.291001,"marketCap":24137841},{"date":"2023-08-04","current":13.478253,"twenty":9.270407,"median":16.623422,"eighty":29.291001,"marketCap":24761963},{"date":"2023-08-11","current":60.420769,"twenty":9.270407,"median":16.707346,"eighty":29.361529,"marketCap":22462569},{"date":"2023-08-18","current":46.77737,"twenty":9.270407,"median":16.751907,"eighty":29.542563,"marketCap":17390376},{"date":"2023-08-25","current":45.607934,"twenty":9.270407,"median":16.784815,"eighty":29.777584,"marketCap":16955616},{"date":"2023-09-01","current":48.284639,"twenty":9.270407,"median":16.804181,"eighty":29.928992,"marketCap":17950732},{"date":"2023-09-08","current":49.064263,"twenty":9.270407,"median":16.842786,"eighty":30.259377,"marketCap":18240572},{"date":"2023-09-15","current":46.829343,"twenty":9.270407,"median":16.935322,"eighty":30.44423,"marketCap":17409698},{"date":"2023-09-22","current":46.77737,"twenty":9.270407,"median":16.965891,"eighty":30.665668,"marketCap":17390376},{"date":"2023-09-29","current":45.997485,"twenty":9.270407,"median":17.013991,"eighty":31.036414,"marketCap":17100439},{"date":"2023-10-06","current":44.2306,"twenty":9.270407,"median":17.081776,"eighty":31.213696,"marketCap":16443566},{"date":"2023-10-13","current":43.528941,"twenty":9.270407,"median":17.194751,"eighty":31.492693,"marketCap":16182711},{"date":"2023-10-20","current":45.218122,"twenty":9.270407,"median":17.223802,"eighty":31.671308,"marketCap":16810696},{"date":"2023-10-27","current":45.92498,"twenty":9.064218,"median":17.230258,"eighty":32.764716,"marketCap":17073484},{"date":"2023-11-03","current":45.503985,"twenty":9.064218,"median":17.320737,"eighty":34.85379,"marketCap":16916971},{"date":"2023-11-10","current":-4.053215,"twenty":6.893469,"median":17.338406,"eighty":35.889354,"marketCap":16907310},{"date":"2023-11-17","current":-3.653684,"twenty":6.83144,"median":17.338406,"eighty":35.889354,"marketCap":15240732},{"date":"2023-11-24","current":-3.810022,"twenty":6.787807,"median":17.338406,"eighty":35.889354,"marketCap":15892871},{"date":"2023-12-01","current":-3.886454,"twenty":6.70711,"median":17.338406,"eighty":35.889354,"marketCap":16211694},{"date":"2023-12-08","current":-3.731274,"twenty":6.666302,"median":17.331865,"eighty":35.887559,"marketCap":15564386},{"date":"2023-12-15","current":-4.034686,"twenty":6.631383,"median":17.331865,"eighty":35.887559,"marketCap":16830019},{"date":"2023-12-22","current":-3.803074,"twenty":6.609152,"median":17.331865,"eighty":35.887559,"marketCap":15863887},{"date":"2023-12-29","current":-3.932777,"twenty":6.595793,"median":17.338406,"eighty":35.889354,"marketCap":16404921},{"date":"2024-01-05","current":-3.821603,"twenty":6.586045,"median":17.344948,"eighty":35.891148,"marketCap":15941178},{"date":"2024-01-12","current":-3.749803,"twenty":6.567001,"median":17.344948,"eighty":35.891148,"marketCap":15641677},{"date":"2024-01-19","current":-3.719693,"twenty":6.55022,"median":17.345704,"eighty":35.892943,"marketCap":15516079},{"date":"2024-01-26","current":-3.821603,"twenty":6.503068,"median":17.344948,"eighty":35.891148,"marketCap":15941178},{"date":"2024-02-02","current":-4.138888,"twenty":6.447763,"median":17.344948,"eighty":35.891148,"marketCap":17264682},{"date":"2024-02-09","current":-3.705797,"twenty":6.410568,"median":17.344948,"eighty":35.891148,"marketCap":15458112},{"date":"2024-02-16","current":-3.508926,"twenty":6.359331,"median":17.344948,"eighty":35.891148,"marketCap":14636899},{"date":"2024-02-23","current":-3.682635,"twenty":6.32419,"median":17.344948,"eighty":35.891148,"marketCap":15361498},{"date":"2024-03-01","current":-3.633997,"twenty":6.231918,"median":17.338406,"eighty":35.889354,"marketCap":15158611},{"date":"2024-03-08","current":-3.497346,"twenty":6.16345,"median":17.338406,"eighty":35.889354,"marketCap":14588593},{"date":"2024-03-15","current":-3.430178,"twenty":6.109048,"median":17.338406,"eighty":35.889354,"marketCap":14308414},{"date":"2024-03-22","current":-3.520507,"twenty":6.064149,"median":17.338406,"eighty":35.889354,"marketCap":14685206},{"date":"2024-03-28","current":-3.792651,"twenty":6.012458,"median":17.338406,"eighty":35.889354,"marketCap":15820411},{"date":"2024-04-05","current":-3.476823,"twenty":-3.430178,"median":17.344948,"eighty":35.891148,"marketCap":15303530},{"date":"2024-04-12","current":-3.424144,"twenty":-3.457045,"median":17.344948,"eighty":35.891148,"marketCap":15071659},{"date":"2024-04-19","current":-3.55255,"twenty":-3.467184,"median":17.344948,"eighty":35.891148,"marketCap":15636846},{"date":"2024-04-26","current":-3.410975,"twenty":-3.476823,"median":17.338406,"eighty":35.889354,"marketCap":15013691},{"date":"2024-05-03","current":-3.575597,"twenty":-3.513699,"median":17.338406,"eighty":35.889354,"marketCap":15738290},{"date":"2024-05-10","current":-3.70071,"twenty":-3.542668,"median":17.329479,"eighty":35.889354,"marketCap":16288985},{"date":"2024-05-17","current":-3.529581,"twenty":-3.542668,"median":17.308266,"eighty":35.889354,"marketCap":15941178},{"date":"2024-05-24","current":-3.583059,"twenty":-3.55255,"median":17.308266,"eighty":35.889354,"marketCap":16182711},{"date":"2024-05-31","current":-3.463267,"twenty":-3.55255,"median":17.278675,"eighty":35.889354,"marketCap":15641677},{"date":"2024-06-07","current":-3.347754,"twenty":-3.55255,"median":17.223802,"eighty":35.889354,"marketCap":15119965},{"date":"2024-06-14","current":-3.240797,"twenty":-3.55255,"median":17.197914,"eighty":35.891148,"marketCap":14636899},{"date":"2024-06-21","current":-3.330641,"twenty":-3.55255,"median":17.081776,"eighty":35.892943,"marketCap":15042675},{"date":"2024-06-28","current":-3.219405,"twenty":-3.552703,"median":17.043042,"eighty":35.901917,"marketCap":14540286},{"date":"2024-07-05","current":-3.003352,"twenty":-3.552703,"median":17.013991,"eighty":35.901917,"marketCap":13564493},{"date":"2024-07-12","current":-3.05897,"twenty":-3.552703,"median":17.013991,"eighty":35.901917,"marketCap":13815687},{"date":"2024-07-15","current":-3.056852,"twenty":-3.552703,"median":17.013991,"eighty":35.901917,"marketCap":13806122},{"date":"2024-08-02","current":-3.296414,"twenty":-3.575597,"median":17.196333,"eighty":36.253685,"marketCap":14888094},{"date":"2024-08-09","current":-3.20871,"twenty":-3.575597,"median":17.157631,"eighty":36.253685,"marketCap":14491980},{"date":"2024-08-16","current":-5.299398,"twenty":-3.583059,"median":17.028517,"eighty":36.253685,"marketCap":16231017},{"date":"2024-08-23","current":-5.990212,"twenty":-3.589991,"median":16.96396,"eighty":36.253685,"marketCap":18346846},{"date":"2024-08-30","current":-6.087999,"twenty":-3.631681,"median":16.836395,"eighty":36.253685,"marketCap":18646347},{"date":"2024-09-06","current":-5.833186,"twenty":-3.647894,"median":16.784815,"eighty":36.253685,"marketCap":17865906},{"date":"2024-09-13","current":-5.435037,"twenty":-3.682635,"median":16.762252,"eighty":36.253685,"marketCap":16646454},{"date":"2024-09-20","current":-5.520206,"twenty":-3.705797,"median":16.65244,"eighty":36.253685,"marketCap":16907310},{"date":"2024-09-27","current":-5.996521,"twenty":-3.731274,"median":16.584688,"eighty":36.253685,"marketCap":18366169},{"date":"2024-10-04","current":-5.677927,"twenty":-3.749803,"median":16.399086,"eighty":36.253685,"marketCap":17390376},{"date":"2024-10-11","current":-5.791485,"twenty":-3.7637,"median":16.229624,"eighty":36.253685,"marketCap":17738183},{"date":"2024-10-18","current":-6.097462,"twenty":-3.77528,"median":16.023978,"eighty":36.253685,"marketCap":18675331},{"date":"2024-10-25","current":-5.810411,"twenty":-3.792651,"median":15.985523,"eighty":36.253685,"marketCap":17796151},{"date":"2024-10-31","current":-5.835647,"twenty":-3.800758,"median":15.967744,"eighty":36.253685,"marketCap":17873442},{"date":"2024-11-08","current":-6.529615,"twenty":-3.810022,"median":15.89678,"eighty":36.269048,"marketCap":19998932},{"date":"2024-11-15","current":-5.199381,"twenty":-3.840192,"median":15.796205,"eighty":36.269048,"marketCap":18433798},{"date":"2024-11-22","current":-4.973203,"twenty":-3.884601,"median":15.666049,"eighty":36.269048,"marketCap":17631909},{"date":"2024-11-29","current":-4.643473,"twenty":-3.933703,"median":15.630552,"eighty":36.269048,"marketCap":16462889},{"date":"2024-12-06","current":-4.605322,"twenty":-3.972151,"median":15.600971,"eighty":36.269048,"marketCap":16327630},{"date":"2024-12-13","current":-4.49632,"twenty":-4.034686,"median":15.529918,"eighty":36.269048,"marketCap":15941178},{"date":"2024-12-20","current":-4.291942,"twenty":-4.07035,"median":15.512228,"eighty":36.269048,"marketCap":15216579},{"date":"2024-12-27","current":-4.360068,"twenty":-4.223816,"median":15.500396,"eighty":36.269048,"marketCap":15458112},{"date":"2025-01-03","current":-4.237441,"twenty":-4.276986,"median":15.385741,"eighty":36.269048,"marketCap":15023352},{"date":"2025-01-10","current":-4.305567,"twenty":-4.31632,"median":15.312084,"eighty":36.284411,"marketCap":15264885},{"date":"2025-01-17","current":-4.343691,"twenty":-4.327912,"median":14.164523,"eighty":36.284411,"marketCap":15400047},{"date":"2025-01-24","current":-4.256516,"twenty":-4.327912,"median":13.781684,"eighty":36.284411,"marketCap":15090981},{"date":"2025-01-31","current":-4.210191,"twenty":-4.327912,"median":13.667569,"eighty":36.284411,"marketCap":14926739},{"date":"2025-02-07","current":-4.185665,"twenty":-4.327912,"median":13.494029,"eighty":36.284411,"marketCap":14839787},{"date":"2025-02-14","current":-4.071214,"twenty":-4.327912,"median":13.430924,"eighty":36.284411,"marketCap":14434012},{"date":"2025-02-21","current":-4.071214,"twenty":-4.327912,"median":13.409889,"eighty":36.284411,"marketCap":14434012},{"date":"2025-02-28","current":-3.951312,"twenty":-4.327912,"median":13.33758,"eighty":36.284411,"marketCap":14008914},{"date":"2025-03-07","current":-3.787809,"twenty":-4.329548,"median":13.23293,"eighty":36.299773,"marketCap":13429234},{"date":"2025-03-14","current":-4.060313,"twenty":-4.329548,"median":13.14695,"eighty":36.299773,"marketCap":14395366},{"date":"2025-03-21","current":-3.711508,"twenty":-4.329548,"median":13.110138,"eighty":36.299773,"marketCap":13158717},{"date":"2025-03-28","current":-3.85321,"twenty":-4.329548,"median":12.894528,"eighty":35.891148,"marketCap":13661106},{"date":"2025-04-04","current":-1.824009,"twenty":-4.329548,"median":12.884011,"eighty":34.73182,"marketCap":10242931},{"date":"2025-04-11","current":-1.634417,"twenty":-4.327912,"median":12.681548,"eighty":31.65097,"marketCap":9178254},{"date":"2025-04-17","current":-1.53119,"twenty":-4.327912,"median":10.113237,"eighty":31.452062,"marketCap":8598574},{"date":"2025-04-25","current":-1.582804,"twenty":-4.329548,"median":10.107291,"eighty":31.184318,"marketCap":8888414},{"date":"2025-04-28","current":-1.754847,"twenty":-4.329548,"median":10.103888,"eighty":31.140207,"marketCap":9854546}],"updateTime":1745957189132}}}